MariMed (OTCMKTS:MRMD – Get Free Report) is anticipated to post its quarterly earnings results after the market closes on Wednesday, March 5th. Analysts expect MariMed to post earnings of ($0.01) per share and revenue of $42.00 million for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
MariMed Price Performance
Shares of OTCMKTS:MRMD opened at $0.11 on Tuesday. The firm’s 50 day moving average price is $0.12 and its 200-day moving average price is $0.15. The company has a quick ratio of 0.73, a current ratio of 1.55 and a debt-to-equity ratio of 1.01. The stock has a market capitalization of $41.96 million, a PE ratio of -2.75 and a beta of 2.81. MariMed has a twelve month low of $0.11 and a twelve month high of $0.34.
MariMed Company Profile
See Also
- Five stocks we like better than MariMed
- What Are Treasury Bonds?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Best Stocks Under $5.00
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.